Outlook Therapeutics (OTLK) Shareholder's Equity Growth (3y) (2018 - 2026)
Outlook Therapeutics (OTLK) Shareholder's Equity Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Outlook Therapeutics |
51.56 Mn |
43.81 Mn |
-21,888.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-68.27% |
| Dec 31, 2025 |
-64.44% |
| Sep 30, 2025 |
-78.47% |
| Jun 30, 2025 |
-56.76% |
| Mar 31, 2025 |
-42.65% |
| Dec 31, 2024 |
-44.70% |
| Sep 30, 2024 |
-161.40% |
| Jun 30, 2024 |
-104.59% |
| Mar 31, 2024 |
-104.08% |
| Dec 31, 2023 |
-32.46% |
| Sep 30, 2023 |
-92.28% |
| Jun 30, 2023 |
-35.75% |
| Mar 31, 2023 |
35.92% |
| Dec 31, 2022 |
35.89% |
| Sep 30, 2022 |
36.47% |
| Jun 30, 2022 |
71.72% |
| Mar 31, 2022 |
48.59% |
| Dec 31, 2021 |
56.77% |
| Sep 30, 2021 |
29.67% |
| Jun 30, 2021 |
43.68% |
